JPMorgan Chase & Co’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,031
Closed -$8.98K 6632
2025
Q1
$8.98K Buy
2,031
+1,079
+113% +$4.77K ﹤0.01% 5460
2024
Q4
$6.66K Buy
952
+65
+7% +$455 ﹤0.01% 5417
2024
Q3
$12.9K Buy
887
+22
+3% +$319 ﹤0.01% 5277
2024
Q2
$63.1K Sell
865
-10
-1% -$729 ﹤0.01% 4817
2024
Q1
$51.8K Sell
875
-484
-36% -$28.6K ﹤0.01% 4961
2023
Q4
$99.5K Hold
1,359
﹤0.01% 4767
2023
Q3
$52.8K Sell
1,359
-428
-24% -$16.6K ﹤0.01% 4890
2023
Q2
$103K Buy
1,787
+1,663
+1,341% +$96K ﹤0.01% 4616
2023
Q1
$8K Hold
124
﹤0.01% 5323
2022
Q4
$3K Sell
124
-146
-54% -$3.53K ﹤0.01% 5320
2022
Q3
$8K Buy
270
+162
+150% +$4.8K ﹤0.01% 5108
2022
Q2
$2K Sell
108
-829
-88% -$15.4K ﹤0.01% 5438
2022
Q1
$76K Sell
937
-1,522
-62% -$123K ﹤0.01% 4855
2021
Q4
$225K Sell
2,459
-592
-19% -$54.2K ﹤0.01% 4477
2021
Q3
$382K Sell
3,051
-1,283
-30% -$161K ﹤0.01% 4096
2021
Q2
$490K Buy
4,334
+1,560
+56% +$176K ﹤0.01% 4008
2021
Q1
$421K Buy
2,774
+2,223
+403% +$337K ﹤0.01% 4137
2020
Q4
$63K Buy
551
+87
+19% +$9.95K ﹤0.01% 4401
2020
Q3
$37K Sell
464
-88
-16% -$7.02K ﹤0.01% 4367
2020
Q2
$60K Buy
552
+137
+33% +$14.9K ﹤0.01% 4160
2020
Q1
$45K Sell
415
-10
-2% -$1.08K ﹤0.01% 4171
2019
Q4
$67K Buy
425
+2
+0.5% +$315 ﹤0.01% 4147
2019
Q3
$62K Buy
423
+69
+19% +$10.1K ﹤0.01% 4164
2019
Q2
$34K Buy
354
+93
+36% +$8.93K ﹤0.01% 4394
2019
Q1
$28K Sell
261
-999
-79% -$107K ﹤0.01% 4417
2018
Q4
$103K Buy
1,260
+1,126
+840% +$92K ﹤0.01% 4036
2018
Q3
$22K Buy
+134
New +$22K ﹤0.01% 4559